术中氙气麻醉预防体外循环心脏手术后谵妄的随机对照试验
本研究为随机、观察者盲法对照试验,纳入190例65岁及以上体外循环心脏手术患者,随机接受氙气或七氟烷麻醉,术后5天内每日筛查谵妄。结果显示总体谵妄发生率为41%,氙气组与七氟烷组无显著差异(42.7% vs 39.4%,P=0.583),OR为1.18(95%CI 0.65-2.16)。结论认为氙气麻醉不能显著降低术后谵妄,不推荐为此目的使用氙气。
要点
- 氙气麻醉未显著降低老年心脏手术患者术后谵妄发生率。
- 氙气组谵妄发生率42.7%,七氟烷组39.4%,差异无统计学意义。
- 基于现有结果,不推荐以预防谵妄为目的使用氙气麻醉。
核心结论
- 在65岁及以上体外循环心脏手术患者中,氙气麻醉相比七氟烷麻醉未显著降低术后谵妄发生率。
- 仅基于该结果,不推荐将氙气用于预防此类患者的术后谵妄。
研究设计与样本
- 随机、观察者盲法、对照临床试验,共纳入190例65岁及以上接受体外循环心脏手术的患者。
- 患者随机分配至氙气或七氟烷麻醉组,体外循环期间均使用丙泊酚维持麻醉。
- 术后前5天每日使用3分钟CAM诊断访谈或CAM-ICU筛查谵妄,并辅以病历回顾等其他方法。
主要发现
- 总体术后谵妄发生率为41%(78/190)。
- 氙气组谵妄发生率为42.7%(41/96),七氟烷组为39.4%(37/94),差异无统计学意义(P=0.583)。
- 氙气对比七氟烷的谵妄OR为1.18(95%CI 0.65-2.16)。
临床怎么用
- 对于65岁及以上体外循环心脏手术患者,不应仅以预防术后谵妄为目的选择氙气麻醉。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Older patients undergoing cardiac surgery have a 40-60% risk of developing postoperative delirium (POD), which is associated with increased morbidity and mortality. In animals, xenon has been found to be neuroprotective. Little is known about its neuroprotective effects in humans. We evaluated whether xenon anaesthesia prevents POD in patients undergoing cardiac surgery. METHODS: We conducted a randomised, observer-blind, controlled trial in which 190 patients 65 yr or older undergoing on-pump cardiac surgery were randomly allocated to xenon or sevoflurane anaesthesia. During cardiopulmonary bypass, propofol infusion was used for anaesthetic maintenance. Subjects were screened for POD daily during the first 5 postoperative days using the 3-Minute Diagnostic Interview for Confusion Assessment Method (CAM) or with a CAM version for patients in ICU (CAM-ICU). Other methods to detect delirium, such as chart review, were also used. Secondary outcomes included the duration and severity of POD, and postoperative cognitive function. RESULTS: The overall incidence of POD was 41% (78/190). There was no statistically significant difference in the POD incidence between the xenon and sevoflurane groups (42.7% [41/96] vs 39.4% [37/94], P=0.583). The odds ratio for POD when comparing xenon with sevoflurane was 1.18 (95% confidence interval, 0.65-2.16). CONCLUSIONS: In older patients undergoing cardiac surgery, xenon anaesthesia did not result in a significant reduction in POD. Based on these results alone, use of xenon cannot be recommended for this purpose. CLINICAL TRIAL REGISTRATION: EudraCT: 2014-005370-11 (May 13, 2015; https://www.clinicaltrialsregister.eu/ctr-search/search?query=2014-005370-11).
引用
- Al Tmimi L, Verbrugghe P, Van de Velde M, et al. Intraoperative xenon for prevention of delirium after on-pump cardiac surgery: a randomised, observer-blind, controlled clinical trial. Br J Anaesth. 2020. PMID: 32005514. doi:10.1016/j.bja.2019.11.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。